Alzheimer’s disease risk up for older adults after COVID-19 infection
Sep 14, 2022
The highest risk for a new diagnosis of Alzheimer’s disease within 360 days after diagnosis was seen for those aged 85 years and older and women.
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.
Transcranial direct current stimulation beneficial in Alzheimer’s disease
Dec 07, 2023
Active tCDS improves cognitive functions in memory domain, including word recall, recall of test instructions and word recognition.
BMI declines seen seven years before cognitive impairment diagnosis
Nov 02, 2022
However, after diagnosis, BMI declines at the same pace in people who develop or do not develop dementia.
Risk for adverse outcomes increased with antipsychotic use in dementia
Apr 19, 2024
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia and acute kidney injury.
New model predicts five-year Alzheimer’s dementia risk
Oct 12, 2022
The model includes demographic information, brain imaging test results and genetic biomarkers.
Number of teeth, periodontitis in older adults linked to hippocampal atrophy
Jul 06, 2023
A qualitative interaction was seen between the number of teeth present and the mean periodontal probing depth for symmetric percentage change in left hippocampus.
Excess mortality seen for seniors with Alzheimer’s disease, dementia in COVID-19
Mar 08, 2022
Enrollees with Alzheimer’s disease and related dementias had increased adjusted mortality, especially for Asian, Black and Hispanic populations.
Solanezumab does not slow cognitive decline in preclinical Alzheimer’s disease
Jul 19, 2023
The mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab or placebo.
Telmisartan linked to reduced risk for Alzheimer’s disease in Black patients
Nov 07, 2022
Black-specific beneficial effects of telmisartan were identified in a Mendelian randomization analysis.